{
  "docId": "019de077-60e9-755b-a2a9-f474a1c234cc",
  "docSlug": "c7a8fd91214a0cf2ae7cadcb747376a3",
  "documentTitle": "MindMed | Investor Presentation Deck | 42 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 42,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 3,
  "notes": "The slide uses a structured layout to compare clinical trial designs across two primary indications.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-60e9-755b-a2a9-f474a1c234cc/11",
  "deckHref": "/decks/019de077-60e9-755b-a2a9-f474a1c234cc",
  "deckJsonHref": "/decks/019de077-60e9-755b-a2a9-f474a1c234cc.json",
  "deckAnchorHref": "/decks/019de077-60e9-755b-a2a9-f474a1c234cc#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.64,
        "x": 0.18,
        "y": 0.1
      },
      "kind": "callout",
      "text": "Aligned clinical trial designs across indications maximize operational efficiencies",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a19fac4-89e1-4e81-8bf0-232f7992b579",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.17,
        "y": 0.91
      },
      "kind": "disclaimer",
      "text": "1. Studies will employ an adaptive design... 2. Clinical study designs subject to ongoing regulatory discussion... 3. Expected first patient dosing. DB: double blind; ODT: orally disintegrating tablet; OL: open-label; RCT: randomized controlled trial",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "822851df-7fd8-48bf-a673-5ebf1145aba9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.27
      },
      "kind": "list",
      "text": "Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD) trial structures",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2883b69b-06ac-4aee-baec-7114f7cd4cd4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.4,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "MM120 ODT Program Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8340d737-4bf3-4089-b938-2901a5c7fb4a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "e4390621-b1f3-449b-bd24-9a80cefcf906",
      "evidence": "list/bullet: Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD) trial structures",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "roadmap",
      "slug": null,
      "matchId": "1fb65dad-2a45-4986-bb5b-97f93c3ad612",
      "evidence": "The slide outlines a structured plan for clinical trials over time.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 7,
      "beatId": "a218c047-f9dd-43b1-b607-76eb8fa90d3b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 7-14 discuss MM120 ODT Lysergide D-tartrate program",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 9,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "7f8a31e9-b9f6-4f56-a068-29db96bdffb0",
      "evidence": "Slides 9-12 discuss the potential to address large unmet needs",
      "position": 0,
      "objective": "Highlight the cost of inaction in addressing brain health disorders",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}